CRISPR Therapeutics AG logo

CRISPR Therapeutics AG

STU:1CG (Switzerland)   Ordinary Shares
€ 40.80 (0%) May 30
At Loss
P/B:
2.19
Market Cap:
€ 4.25B ($ 4.61B)
Enterprise V:
€ 2.52B ($ 2.73B)
Volume:
-
Avg Vol (2M):
-
Also Trade In:

CRISPR Therapeutics AG Valuation Measures